Are you an EPFL student looking for a semester project?
Work with us on data science and visualisation projects, and deploy your project as an app on top of GraphSearch.
The Fondation Innovative Medicines for Tuberculosis (iM4TB) is a non-profit organization based at EPFL dedicated to developing better and faster-acting medicines to combat all forms of tuberculosis. With a team of experienced researchers, iM4TB focuses on finding new molecules that can effectively kill the TB bacterium without harming patients. The foundation has received significant funding, including a grant from the Bill & Melinda Gates Foundation, to support the development of their innovative anti-tuberculosis drug PBTZ169. iM4TB's mission is crucial in the global fight against tuberculosis, a disease that claims the lives of three individuals every minute worldwide.
Stewart Cole, Florence Pojer, Gaëlle Séraphine Kolly, Jan Lars Rybniker, Jeffrey Chen